Browse by author
Lookup NU author(s): James Connolly, John Davis, David Green, Dr Cara Tomas-Smith, Dr Barbara Wilson, Fiona Yelnoorkar
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND).
© 2021 The Author(s)Background: Lateral flow device (LFD) viral antigen immunoassays have been developed around the world as diagnostic tests for SARS-CoV-2 infection. They have been proposed to deliver an infrastructure-light, cost-economical solution giving results within half an hour. Methods: LFDs were initially reviewed by a Department of Health and Social Care team, part of the UK government, from which 64 were selected for further evaluation from 1st August to 15th December 2020. Standardised laboratory evaluations, and for those that met the published criteria, field testing in the Falcon-C19 research study and UK pilots were performed (UK COVID-19 testing centres, hospital, schools, armed forces). Findings: 4/64 LFDs so far have desirable performance characteristics (orient Gene, Deepblue, Abbott and Innova SARS-CoV-2 Antigen Rapid Qualitative Test). All these LFDs have a viral antigen detection of >90% at 100,000 RNA copies/ml. 8951 Innova LFD tests were performed with a kit failure rate of 5.6% (502/8951, 95% CI: 5.1–6.1), false positive rate of 0.32% (22/6954, 95% CI: 0.20–0.48). Viral antigen detection/sensitivity across the sampling cohort when performed by laboratory scientists was 78.8% (156/198, 95% CI 72.4–84.3). Interpretation: Our results suggest LFDs have promising performance characteristics for mass population testing and can be used to identify infectious positive individuals. The Innova LFD shows good viral antigen detection/sensitivity with excellent specificity, although kit failure rates and the impact of training are potential issues. These results support the expanded evaluation of LFDs, and assessment of greater access to testing on COVID-19 transmission. Funding: Department of Health and Social Care. University of Oxford. Public Health England Porton Down, Manchester University NHS Foundation Trust, National Institute of Health Research.
Author(s): Peto T, Affron D, Afrough B, Agasu A, Ainsworth M, Allanson A, Allen K, Allen C, Archer L, Ashbridge N, Aurfan I, Avery M, Badenoch E, Bagga P, Balaji R, Baldwin E, Barraclough S, Beane C, Bell J, Benford T, Bird S, Bishop M, Bloss A, Body R, Boulton R, Bown A, Bratten C, Bridgeman C, Britton D, Brooks T, Broughton-Smith M, Brown P, Buck B, Butcher E, Byrne W, Calderon G, Campbell S, Carr O, Carter P, Carter D, Cathrall M, Catton M, Chadwick J, Chapman D, Chau KK, Chaudary T, Chidavaenzi S, Chilcott S, Choi B, Claasen H, Clark S, Clarke R, Clarke D, Clayton R, Collins K, Colston R, Connolly J, Cook E, Corcoran M, Corley B, Costello L, Coulson C, Crook A, Crook DW, D'Arcangelo S, Darby M-A, Davis J, de Koning R, Derbyshire P, Devall P, Dolman M, Draper N, Driver M, Dyas S, Eaton E, Edwards J, Elderfield R, Ellis K, Ellis G, Elwell S, Evans R, Evans B, Evans M, Evans R, Eyre D, Fahey C, Fenech V, Field J, Field A, Foord T, Fowler T, French M, Fuchs H, Gan J, Gernon J, Ghadiali G, Ghuman N, Gibbons K, Gill G, Gilmour K, Goel A, Gordon S, Graham T, Grassam-Rowe A, Green D, Gronert A, Gumsley-Read T, Hall C, Hallis B, Hammond S, Hammond P, Hanney B, Hardy V, Harker G, Harris A, Havinden-Williams M, Hazell E, Henry J, Hicklin K, Hollier K, Holloway B, Hoosdally SJ, Hopkins S, Hughes L, Hurdowar S, Hurford S-A, Jackman J, Jackson H, Johns R, Johnston S, Jones J, Kanyowa T, Keating-Fedders K, Kempson S, Khan I, Khulusi B, Knight T, Krishna A, Lahert P, Lampshire Z, Lasserson D, Lee K, Lee LYW, Legard A, Leggio C, Liu J, Lockett T, Logue C, Lucas V, Lumley SF, Maripuri V, Markham D, Marshall E, Matthews PC, Mckee S, McKee DF, McLeod N, McNulty A, Mellor F, Michel R, Mighiu A, Miller J, Mirza Z, Mistry H, Mitchell J, Moeser ME, Moore S, Muthuswamy A, Myers D, Nanson G, Newbury M, Nicol S, Nuttall H, Nwanaforo JJ, Oliver L, Osbourne W, Osbourne J, Otter A, Owen J, Panchalingam S, Papoulidis D, Pavon JD, Peace A, Pearson K, Peck L, Pegg A, Pegler S, Permain H, Perumal P, Peto L, Peto TEA, Pham T, Pickford HL, Pinkerton M, Platton M, Price A, Protheroe E, Purnell H, Rawden L, Read S, Reynard C, Ridge S, Ritter TG, Robinson J, Robinson P, Rodger G, Rowe C, Rowell B, Rowlands A, Sampson S, Saunders K, Sayers R, Sears J, Sedgewick R, Seeney L, Selassie A, Shail L, Shallcross J, Sheppard L, Sherkat A, Siddiqui S, Sienkiewicz A, Sinha L, Smith J, Smith E, Stanton E, Starkey T, Stawiarski A, Sterry A, Stevens J, Stockbridge M, Stoesser N, Sukumaran A, Sweed A, Tatar S, Thomas H, Tibbins C, Tiley S, Timmins J, Tomas-Smith C, Topping O, Turek E, Neibler T, Trigg-Hogarth K, Truelove E, Turnbull C, Tyrrell D, Vaughan A, Vertannes J, Vipond R, Wagstaff L, Waldron J, Walker P, Walker AS, Walters M, Wang JY, Watson E, Webberley K, Webster K, Westland G, Wickens I, Willcocks J, Willis H, Wilson S, Wilson B, Woodhead L, Wright D, Xavier B, Yelnoorkar F, Zeidan L, Zinyama R
Publication type: Article
Publication status: Published
Journal: EClinicalMedicine
Year: 2021
Volume: 36
Print publication date: 29/06/2021
Online publication date: 30/05/2021
Acceptance date: 07/05/2021
Date deposited: 23/06/2021
ISSN (electronic): 2589-5370
Publisher: Lancet Publishing Group
URL: https://doi.org/10.1016/j.eclinm.2021.100924
DOI: 10.1016/j.eclinm.2021.100924
Altmetrics provided by Altmetric
